Neurogene (NGNE) Interest & Investment Income (2013 - 2026)

Neurogene (NGNE) has 12 years of Interest & Investment Income data on file, last reported at $2.3 million in Q1 2026.

• Quarterly Interest & Investment Income fell 29.48% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (up 13.34% YoY) and the FY2025 annual result came in at $11.5 million, up 36.38% from the prior year.
• Interest & Investment Income declined to $2.3 million in Q1 2026, from $2.7 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.2 million in Q1 2025 to a low of $650000.0 in Q3 2023.
• A 4-year average of $1.9 million and a median of $2.3 million in 2026 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2024 — Interest & Investment Income jumped 198.58% — and 2026, when it decreased 29.48%.
• Tracing NGNE's Interest & Investment Income over 4 years: stood at $781000.0 in 2023, then soared by 190.65% to $2.3 million in 2024, then advanced by 17.75% to $2.7 million in 2025, then dropped by 15.41% to $2.3 million in 2026.
• The last three Interest & Investment Income figures came in at $2.3 million (Q1 2026), $2.7 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.